• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

An early innate response underlies severe influenza-induced exacerbations of asthma in a novel steroid-insensitive and anti-IL-5 responsive mouse mode

tetano

Editor, Senior Moderator
Allergy. 2016 Oct 3. doi: 10.1111/all.13057. [Epub ahead of print]
[h=1]An early innate response underlies severe influenza-induced exacerbations of asthma in a novel steroid-insensitive and anti-IL-5 responsive mouse model.[/h] Ravanetti L[SUP]1,[/SUP][SUP]2[/SUP], Dijkhuis A[SUP]3,[/SUP][SUP]4[/SUP], Sabogal Pineros YS[SUP]3,[/SUP][SUP]4[/SUP], Bal SM[SUP]5[/SUP], Dierdorp BS[SUP]3[/SUP], Dekker T[SUP]3[/SUP], Logiantara A[SUP]3[/SUP], Adcock IM[SUP]6[/SUP], Rao NL[SUP]7[/SUP], Boon L[SUP]8[/SUP], Villetti G[SUP]9[/SUP], Sterk PJ[SUP]4[/SUP], Facchinetti F[SUP]9[/SUP], Lutter R[SUP]3,[/SUP][SUP]4[/SUP]; U-BIOPRED Study Group..
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Acute worsening of asthma symptoms (exacerbation) is predominantly triggered by respiratory viruses, with influenza causing the most severe exacerbations. The lack of an adequate animal model hampers mechanistic insight and the development of new therapeutics.
[h=4]AIM:[/h] We developed and characterized a robust, consistent and reproducible mouse model of severe exacerbation of chronic allergic asthma.
[h=4]METHODS:[/h] Chronic allergic airway inflammation was induced following a house dust mite (HDM)-sensitization protocol. HDM-sensitized mice and controls were infected with influenza virus A/X31 H3N2 and either or not treated with inhaled Fluticasone Propionate (FP), systemic corticosteroids (Pred) or anti-IL5. Mice were sacrificed at different time points after infection: cellular accumulation and cytokines levels in the airways; PenH as a measure of airway hyperresponsiveness (AHR); lung histology and viral replication were assessed.
[h=4]RESULTS:[/h] Infection with low dose A/X31 H3N2 led to prolonged deterioration of lung function, aggravated mucus production, peri-vascular, peri-bronchial and allergic inflammation that was unresponsive to inhaled corticosteroids, but responsive to systemic corticosteroids. The exacerbation was preceded at 14h after virus exposure by a marked innate, but no Th2 and Th1 response, subsequently followed by enhanced numbers of eosinophils, neutrophils, dendritic and T cells into the lung lumen, parenchyma and draining lymph nodes in HDM-sensitized mice. Anti-IL-5 treatment attenuated eosinophils and prevented the X31-induced exacerbation.
[h=4]CONCLUSIONS:[/h] Together these findings indicate that an early innate response that involves eosinophils underlies the exacerbation. This model recapitulates all major features of severe asthma exacerbations and can serve to discern driving mechanisms and promote development of novel therapeutics. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.


PMID: 27696462 DOI: 10.1111/all.13057
[PubMed - as supplied by publisher]
 
Back
Top Bottom